Ad is loading...
BIAYX vs NAESX
BIAYX vs NAESX Comparison
Open Charts BIAYX vs NAESX
Brown Advisory Sustainable Sml-Cp Cr I
Price$9.13
Change+$0.73 (+8.69%)
VolumeN/A
Net Assets84.87M
Vanguard Small Cap Index I
Price$101.55
Change+$8.70 (+9.37%)
VolumeN/A
Net Assets143.36B
BIAYX vs NAESX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 143B vs. BIAYX (84.9M). NAESX pays higher dividends than BIAYX: NAESX (1.39) vs BIAYX (0.54). BIAYX was incepted earlier than NAESX: BIAYX (4 years) vs NAESX (65 years). BIAYX (1.23) is less costly to investors than NAESX (0.17). BIAYX is a more actively managed with annual turnover of: 32.00 vs. NAESX (12.00). BIAYX has a lower initial minimum investment than NAESX: BIAYX (100) vs NAESX (3000). NAESX annual gain was more profitable for investors over the last year : -13.70 vs. BIAYX (-15.41).
| BIAYX | NAESX | BIAYX / NAESX | |
| Total Expense Ratio | 1.09 | 0.17 | 641% |
| Annual Report Gross Expense Ratio | 1.23 | 0.17 | 724% |
| Fund Existence | 4 years | 65 years | - |
| Gain YTD | -17.404 | -19.296 | 90% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100 | 3000 | 3% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 84.9M | 143B | 0% |
| Annual Yield % from dividends | 0.54 | 1.39 | 38% |
| Returns for 1 year | -15.41 | -13.70 | 113% |
| Returns for 3 years | -5.46 | -5.18 | 105% |
| Returns for 5 years | N/A | 56.35 | - |
| Returns for 10 years | N/A | 63.14 | - |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| KAPR | 29.90 | 1.40 | +4.92% |
| Innovator Russell 2000 Pwr Bffr ETF Apr | |||
| JANW | 32.71 | 1.39 | +4.44% |
| AllianzIM US Large Cap Buffer20 Jan ETF | |||
| EBND | 20.04 | 0.46 | +2.35% |
| SPDR® Blmbg Em Mkts Lcl Bd ETF | |||
| RPHS | 9.60 | 0.20 | +2.14% |
| Regents Park Hedged Market Strategy ETF | |||
| BIS | 21.27 | -2.58 | -10.84% |
| ProShares UltraShort Nasdaq Biotech | |||